Intestinal group 1 innate lymphoid cells drive macrophage-induced inflammation and endocrine defects in obesity and promote insulinemia

References

• Roselli M, Canali R, Finamore A, Ghiselli A, Devirgilis C. Immune system, gut microbiota and diet: an interesting and emerging trialogue. IntechOpen. 2022. doi:10.5772/intechopen.104121.
   Google Scholar
• Eberl G. Immunity by equilibrium. Nat Rev Immunol. 2016;16:524–14. doi:10.1038/nri.2016.75.
   PubMed Web of Science ®Google Scholar
• Winer DA, Luck H, Tsai S, Winer S. The intestinal immune system in obesity and insulin resistance. Cell Metab. 2016;23:413–426. doi:10.1016/j.cmet.2016.01.003.
   PubMed Web of Science ®Google Scholar
• Liébana-García R, Olivares M, Bullich-Vilarrubias C, López-Almela I, Romaní-Pérez M, Sanz Y. The gut microbiota as a versatile immunomodulator in obesity and associated metabolic disorders. Best Pract Res Clin Endocrinol Metab. 2021;35:101542. doi:10.1016/j.beem.2021.101542.
   PubMed Web of Science ®Google Scholar
• Garidou L, Pomié C, Klopp P, Waget A, Charpentier J, Aloulou M, Giry A, Serino M, Stenman L, Lahtinen S, et al. The gut microbiota regulates intestinal CD4 T cells expressing RORγt and controls metabolic disease. Cell Metab. 2015;22:100–112. doi:10.1016/j.cmet.2015.06.001.
   PubMed Web of Science ®Google Scholar
• Khan S, Luck H, Winer S, Winer DA. Emerging concepts in intestinal immune control of obesity-related metabolic disease. Nat Commun. 2021;12:2598. doi:10.1038/s41467-021-22727-7.
   PubMed Web of Science ®Google Scholar
• Gury-BenAri M, Thaiss CA, Serafini N, Winter DR, Giladi A, Lara-Astiaso D, Levy M, Salame TM, Weiner A, David E, et al. The spectrum and regulatory landscape of intestinal innate lymphoid cells are shaped by the microbiome. Cell. 2016;166:1231-1246.
   PubMed Web of Science ®Google Scholar
• Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie ANJ, Mebius RE, et al. Innate lymphoid cells: 10 years on. Cell. 2018;174:1054–1066. doi:10.1016/j.cell.2018.07.017.
   PubMed Web of Science ®Google Scholar
• Wang X, Ota N, Manzanillo P, Kates L, Zavala-Solorio J, Eidenschenk C, Zhang J, Lesch J, Lee WP, Ross J, et al. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nature. 2014;514:237–241. doi:10.1038/nature13564.
   PubMed Web of Science ®Google Scholar
• Zou J, Chassaing B, Singh V, Pellizzon M, Rici M, Fythe MD, Kumar MV, Gewirtz AT. Fiber-mediated nourishment of gut microbiota protects against diet-induced obesity by restoring IL-22-mediated colonic health. Cell Host Microbe. 2018;23:41–53. doi:10.1016/j.chom.2017.11.003.
   PubMed Web of Science ®Google Scholar
• Mao K, Baptista AP, Tamoutounour S, Zhuang L, Bouladoux N, Martins AJ, Huang Y, Gerner MY, Belkaid Y, Germain RN, et al. Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism. Nature. 2018;554:255–259. doi:10.1038/nature25437.
   PubMed Web of Science ®Google Scholar
• Zeng B, Shi S, Ashworth G, Dong C, Liu J, Xing F. ILC3 function as a double-edged sword in inflammatory bowel diseases. Cell Death Dis. 2019;10:315. doi:10.1038/s41419-019-1540-2.
   PubMed Web of Science ®Google Scholar
• Castellanos JG, Woo V, Viladomiu M, Putzel G, Lima S, Diehl GE, Marderstein AR, Gandara J, Perez AR, Withers DR, et al. Microbiota-induced TNF-like ligand 1A drives group 3 innate lymphoid cell-mediated barrier protection and intestinal T cell activation during colitis. Immunity. 2018;49(6):1077–1089. doi:10.1016/j.immuni.2018.10.014.
   PubMed Web of Science ®Google Scholar
• Brestoff JR, Kim BS, Saenz SA, Stine RR, Monticelli LA, Sonnenberg GF, Thome JJ, Farber DL, Lutfy K, Seale P, et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature. 2015;519(7542):242–246. doi:10.1038/nature14115.
   PubMed Web of Science ®Google Scholar
• Lee B-C, Kim M-S, Pae M, Yamamoto Y, Eberlé D, Shimada T, Kamei N, Park H-S, Sasorith S, Woo J, et al. Adipose natural killer cells regulate adipose tissue macrophages to promote insulin resistance in obesity. Cell Metab. 2016;23(4):685–698. doi:10.1016/j.cmet.2016.03.002.
   PubMed Web of Science ®Google Scholar
• O’Sullivan TE, Rapp M, Fan X, Weizman O-E, Bhardwaj P, Adams NM, Walzer T, Dannenberg AJ, Sun JC. Adipose-resident group 1 innate lymphoid cells promote obesity-associated insulin resistance. Immunity. 2016;45(2):428–441. doi:10.1016/j.immuni.2016.06.016.
   PubMed Web of Science ®Google Scholar
• Wang H, Shen L, Sun X, Liu F, Feng W, Jiang C, Chu X, Ye X, Jiang C, Wang Y, et al. Adipose group 1 innate lymphoid cells promote adipose tissue fibrosis and diabetes in obesity. Nat Commun. 2019;10(1):3254. doi:10.1038/s41467-019-11270-1.
   PubMedGoogle Scholar
• Sasaki T, Moro K, Kubota T, Kubota N, Kato T, Ohno H, Nakae S, Saito H, Koyasu S. Innate lymphoid cells in the induction of obesity. Cell Rep. 2019;28:202-217.
   PubMed Web of Science ®Google Scholar
• Boulenouar S, Michelet X, Duquette D, Alvarez D, Hogan AE, Dold C, O’Connor D, Stutte S, Tavakkoli A, Winters D, et al. Adipose type one innate lymphoid cells regulate macrophage homeostasis through targeted cytotoxicity. Immunity. 2017;46:273–286. doi:10.1016/j.immuni.2017.01.008.
   PubMed Web of Science ®Google Scholar
• Okamura T, Hashimoto Y, Majima S, Senmaru T, Ushigome E, Nakanishi N, Asano M, Yamazaki M, Takakuwa H, Hamaguchi M, et al. Trans fatty acid intake induces intestinal inflammation and impaired glucose tolerance. Front Immunol 2021;12.https://www.frontiersin.org/articles/10.3389/fimmu.2021.669672 (accessed 19 Aug 2022).
   Web of Science ®Google Scholar
• Li J, Doty AL, Iqbal A, Glover SC. The differential frequency of Lineage(-)CRTH2(-)CD45(+)NKp44(-)CD117(-)CD127(+)ILC subset in the inflamed terminal ileum of patients with Crohn’s disease. Cell Immunol. 2016;304–305:63–68. doi:10.1016/j.cellimm.2016.05.001.
   PubMed Web of Science ®Google Scholar
• Forkel M, van Tol S, Höög C, Michaëlsson J, Almer S, Mjósberg J. Distinct alterations in the composition of mucosal innate lymphoid cells in newly diagnosed and established crohn’s disease and ulcerative colitis. J Crohns Colitis. 2019;13:67–78. doi:10.1093/ecco-jcc/jjy119.
   PubMed Web of Science ®Google Scholar
• Wensveen FM, Jelenčić V, Valentić S, Šestan M, Wensveen TT, Theurich S, Glasner A, Mendrila D, Štimac D, Wunderlich FT, et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol. 2015;16:376–385. doi:10.1038/ni.3120.
   PubMed Web of Science ®Google Scholar
• Taouis M, Benomar Y. Is resistin the master link between inflammation and inflammation-related chronic diseases? Mol Cell Endocrinol. 2021;533:111341. doi:10.1016/j.mce.2021.111341.
   PubMed Web of Science ®Google Scholar
• Obradovic M, Sudar-Milovanovic E, Soskic S, Essack M, Arya S, Stewart AJ, Gojobori T, Isenovic ER. Leptin and obesity: role and clinical implication. Front Endocrinol (Lausanne). 2021;12:585887. doi:10.3389/fendo.2021.585887.
   PubMed Web of Science ®Google Scholar
• Everard A, Lazarevic V, Gaïa N, Johansson M, Ståhlman M, Backhed F, Delzenne NM, Schrenzel J, François P, Cani PD, et al. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J. 2014;8(10):2116–2130. doi:10.1038/ismej.2014.45.
   PubMed Web of Science ®Google Scholar
• Lin Y-H, Luck H, Khan S, Schneeberger PHH, Tsai S, Clemente-Casares X, Lei H, Leu Y-L, Chan YT, Chen H-Y, et al. Aryl hydrocarbon receptor agonist indigo protects against obesity-related insulin resistance through modulation of intestinal and metabolic tissue immunity. Int J Obes (Lond). 2019;43(12):2407–2421. doi:10.1038/s41366-019-0340-1.
   PubMed Web of Science ®Google Scholar
• Lebrun LJ, Lenaerts K, Kiers D, Pais de Barros J-P, Le Guern N, Plesnik J, Thomas C, Bourgeois T, Dejong CHC, Kox M, et al. Enteroendocrine L cells sense LPS after gut barrier injury to enhance GLP-1 secretion. Cell Rep. 2017;21(5):1160–1168. doi:10.1016/j.celrep.2017.10.008.
   PubMed Web of Science ®Google Scholar
• Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009;58(8):1091–1103. doi:10.1136/gut.2008.165886.
   PubMed Web of Science ®Google Scholar
• Deacon CF. Physiology and pharmacology of DPP-4 in glucose homeostasis and the treatment of type 2 diabetes. Front Endocrinol (Lausanne). 2019:10. doi:10.3389/fendo.2019.00080.
   Web of Science ®Google Scholar
• Romacho T, Sell H, Indrakusuma I, Roehrborn D, Castañeda TR, Jelenik T, Markgraf D, Hartwig S, Weiss J, Al-Hasani H, et al. DPP4 deletion in adipose tissue improves hepatic insulin sensitivity in diet-induced obesity. American J Physio Endocrinol Meta. 2020;318(5):E590–9. doi:10.1152/ajpendo.00323.2019.
   PubMed Web of Science ®Google Scholar
• Natividad JM, Lamas B, Pham HP, Michel M-L, Rainteau D, Bridonneau C, da Costa G, van Hylckama Vlieg J, Sovran B, Chamignon C, et al. Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice. Nat Commun. 2018;9(1):2802. doi:10.1038/s41467-018-05249-7.
   PubMed Web of Science ®Google Scholar
• Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L, Chilloux J, Ottman N, Duparc T, Lichtenstein L, et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med. 2017;23(1):107–113. doi:10.1038/nm.4236.
   PubMed Web of Science ®Google Scholar
• Molinaro A, Bel Lassen P, Henricsson M, Wu H, Adriouch S, Belda E, Chakaroun R, Nielsen T, Bergh PO, Rouault C, et al. Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology. Nat Commun. 2020;11. doi:10.1038/s41467-020-19589-w.
   Web of Science ®Google Scholar
• Lee L-C, Hou Y-C, Hsieh -Y-Y, Chen Y-H, Shen Y-C, Lee I-J, Monica Shih M-C, Hou W-C, Liu H-K. Dietary supplementation of rutin and rutin-rich buckwheat elevates endogenous glucagon-like peptide 1 levels to facilitate glycemic control in type 2 diabetic mice. J Funct Foods. 2021;85:104653. doi:10.1016/j.jff.2021.104653.
   Web of Science ®Google Scholar
• Le TT, Ziemba A, Urasaki Y, Hayes E, Brotman S, Pizzorno G. Disruption of uridine homeostasis links liver pyrimidine metabolism to lipid accumulation. J Lipid Res. 2013;54(4):1044–1057. doi:10.1194/jlr.M034249.
   PubMed Web of Science ®Google Scholar
• Chen T, Qin Y, Chen M, Zhang Y, Wang X, Dong T, Chen G, Sun X, Lu T, White RA, et al. Gestational diabetes mellitus is associated with the neonatal gut microbiota and metabolome. BMC Med. 2021;19(1):120. doi:10.1186/s12916-021-01991-w.
   PubMed Web of Science ®Google Scholar
• Liu Y, Xie C, Zhai Z, Deng Z-Y, De Jonge HR, Wu X, Ruan Z. Uridine attenuates obesity, ameliorates hepatic lipid accumulation and modifies the gut microbiota composition in mice fed with a high-fat diet. Food Funct. 2021;12:1829–1840. doi:10.1039/D0FO02533J.
   PubMed Web of Science ®Google Scholar
• Steculorum SM, Paeger L, Bremser S, Evers N, Hinze Y, Idzko M, Kloppenburg P, Brüning J. Hypothalamic UDP increases in obesity and promotes feeding via P2Y6-dependent activation of AgRP neurons. Cell. 2015;162(6):1404–1417. doi:10.1016/j.cell.2015.08.032.
   PubMed Web of Science ®Google Scholar
• Matsumoto A, Kanai T, Mikami Y, Chu P, Nakamoto N, Ebinuma H, Saito H, Sato T, Yagita H, Hibi T, et al. IL-22-producing RORγt-dependent innate lymphoid cells play a novel protective role in murine acute hepatitis. PLOS ONE. 2013;8(4):e62853. doi:10.1371/journal.pone.0062853.
   PubMed Web of Science ®Google Scholar
• Olivares M, Rodriguez J, Pötgens SA, Neyrinck AM, Cani PD, Bindels LB, Delzenne NM. The janus face of cereals: wheat-derived prebiotics counteract the detrimental effect of gluten on metabolic homeostasis in mice fed a high-fat/high-sucrose diet. Mol Nutr Food Res. 2019;63:e1900632. doi:10.1002/mnfr.201900632.
   PubMed Web of Science ®Google Scholar
• López-Almela I, Romaní-Pérez M, Bullich-Vilarrubias C, Benítez-Páez A, Gómez Del Pulgar EM, Francés R, Liebisch G, Sanz Y. Bacteroides uniformis combined with fiber amplifies metabolic and immune benefits in obese mice. Gut Microbes. 2021;13:1–20. doi:10.1080/19490976.2020.1865706.
   PubMed Web of Science ®Google Scholar
• Liébana-García R, Olivares M, Rodríguez-Ruano SM, Tolosa-Enguís V, Chulia I, Gil-Martínez L, Guillamón E, Baños A, Sanz Y. The allium derivate propyl propane thiosulfinate exerts anti-obesogenic effects in a murine model of diet-induced obesity. Nutrients. 2022;14(3):440. doi:10.3390/nu14030440.
   PubMed Web of Science ®Google Scholar